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1. Introduction
Improvements in medical care have significantly extended life expectancies, 
upwardly shifting demographic indicators of the elderly worldwide. Coupled with 
falling birth rates, however, the number of patients suffering cognitive deficits has 
also increased. World Health Organization projections, for example, indicate that 
by 2050, more than 20% will fall in this sector, with considerably higher percent-
ages in developed nations, placing large numbers of individuals at risk [1]. Among 
the elderly the most prevalent neurodegenerative disease is Alzheimer’s disease 
(AD) with a lifetime risk above 60 of 33% for males and 45% for females. Its growth 
rate is anticipated to exceed nearly 100% that of current levels in developed nations 
and more than 300% in Southeast Asian countries [2]. These increases in age-
related diseases, moreover, add to an already significant burden from such prevalent 
mental health diseases as schizophrenia and bipolar disorder.
Symptomatically, prevalent diseases like AD and Korsakoff ’s syndrome, exhibit 
profound memory losses. In AD a broad consensus posits that its early symptoms 
include memory lapses that involve episodic memory, semantic recall, and visual 
orienting [3]. Among its earliest is an impaired sense of smell, a feature that may 
relate to evolutionary survival value. With the progression of AD, recent memories 
fade, and there is a proportionately greater retention of older  
ones, a characteristic observation termed Ribot’s law.
Defined as a process of encoding, storing, and retrieving sensorial or mental 
information, memory dysfunctions induced by AD may be functionally interpreted 
as to the manner by which one or more of these phases are affected. Accordingly, 
the loss of formed memories, or retrograde amnesia, observed in AD patients, can 
be explained either by a loss of stored memories or an inability to retrieve them. In 
fact, existing evidence suggests that both phases are affected. Anatomical studies, 
for example, show a deterioration of thinly myelinated regions like the hippocam-
pus relatively early in the disease progression compared to other regions [4]. Since 
the hippocampus is a critical center for recently formed memories, this evidence is 
consistent with loss of memories, particularly those that have formed first.
On the other hand, the disease is known to also specifically affect DMN 
operation [5], a domain thought to be critical to forming the self-construct. First 
identified by nuclear imaging studies that showed consistently higher levels of 
activity during passive task conditions, the DMN was hypothesized to monitor 
the external environment, body, and even emotions [6]. Task-related increases in 
activity in regional brain zones coincided with its decreased activity, indicating a 
reciprocal relation between the two zones related to the performance state of the 
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task. Functional MRI shows that these relative activity levels are substantially and 
progressively altered by Alzheimer’s disease [7]. For example, in AD patients the 
posterior cingulate and right inferior temporal cortical activities decline, whereas 
the activity of the bilateral inferior parietal cortex increases. Because the zones form 
central connectivity hubs within the DMN, the activity changes appear to reflect a 
weakening of causally influential relations among its principal nuclei. Metastability 
indices for AD patients, for example, are reduced in decoupled, desynchronized 
states, revealing that the disease progression significantly reduces the brain’s ability 
to entrain regional dynamical activity [8].
Unlike AD, on the other hand, Korsakoff’s syndrome manifests as a persistent 
memory impairment that associates chiefly with the acquisition of new information 
[9–12]. Accordingly, it has been frequently classified as a disease yielding an antero-
grade form of amnesia. Like AD, on the other hand, its influence is multipronged, with 
studies showing that it also affects memory retrieval. Moreover, other studies show a 
preponderance of perifunctional influences rather than direct influences on episodic 
and semantic memory per se. For example, context memory, which makes an important 
contribution to memory recollection, has been shown to be significantly impaired in 
Korsakoff’s patient. In memory tests, additionally, differential impairments are seen 
between AD and Korsakoff’s disease and also Huntingdon’s disease. For example, KS 
and HD patients performed considerably better than AD patients in recall memory [13].
The complexity of the influences of the two diseases on memory, notwithstand-
ing, the distinctions in their manifestation suggest that these could be exploited 
both to resolve the likely etiological differences between the two and also to gain 
insight into underlying processes of memory and its relation to the self-construct. 
Differences in phenotypic manifestation, notably, have motivated much research, 
on the presupposition that they reflect the presence of different processes contrib-
uting to a single, albeit complex, function. Moreover, differences in manifestation 
also have bearing on therapeutic interventions and managed patient care, illus-
trated in the chapters of this edited volume.
Research into diseases like hemophilia has traditionally sought to resolve under-
lying etiopathological features by exploring genetic and biochemical differences 
that traced their manifestations to single, albeit critical, constituents of biochemical 
mechanisms, like the coagulation defects of Factor VIII in hemophiliac patients 
[14]. Cognitive diseases, on the other hand, are likely to differ greatly from those 
with such ‘metabolite-like features due to the nervous systems’s global role in inte-
grating organismal function. Thus numerous aspects affected by these diseases are 
likely to differ, including their manner of functioning, composition, and hierarchy 
[15, 16]. Hence, there is the question of whether traditional strategies based on 
reductive approaches that attempt to determine etiology from genetic or molecular 
origins are an adequate beginning for investigating normal or disease-affected 
cognition. Indeed, the present volume illustrates both the challenge and the enig-
matic character of such diseases. Accordingly, it is the intention of this introductory 
chapter to consider the limitations to study emerging from the adoption of such 
reductive strategies and the prospects of exploiting “higher-order differences” of 
the sort seen in AD and Korsakoff ’s disease, to infer etiopathological origins.
2. Approaching etiology through risk alleles
Clinically, the identification of risk alleles has significantly benefitted medical diag-
nosis and therapy. For example, diagnosis of the risk allele for hemophilia A, Factor VIII 
has high predictive power of, for example, likely hematoma  when the hemophilia patient 
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is injured. Its utility, however, extends beyond risk prediction. Because mutant alleles 
usually constitute sources of malfunctioning protein products, genetic identification of 
the product can afford access to an otherwise enigmatic etiology. Studies of the Factor 
VIII allele have facilitated, for example, the determination of the disease’s genetic basis, 
the role of the Factor VIII protein in clotting, and moleular therapeutic options [17].
The strategy of investigating etiology via risk alleles is a legacy of experimental 
designs that were successfully pursued for the elucidation of biochemical pathways. 
The presupposition behind these early, now classical approaches conceived of such 
pathways as linear sequences of progressively altered metabolite products, where 
each succeeding step entailed a molecular modification and the succession of steps 
yielded a unique biochemical product. Biochemical pathways fit this decidedly 
causal and prototypical model. The successive conversion of glucose to pyruvate 
in the glycolytic pathway, for example, evidenced the stepwise deconstruction 
by which the larger glucose molecule was gradually disassembled to the smaller 
pyruvate metabolite. Alleles controlled individual steps through their enzymatic 
products, which regulated each biochemical change. By rendering the protein prod-
ucts nonfunctional through techniques like mutagenesis given steps of the pathway 
could be arrested.
Such mutagenesis strategies achieved remarkable success in elucidating pathway 
steps due to the high specificity and mono-functionality of the enzymes regulating 
metabolite conversion. Mutation of the gene loci notably yielded focal and highly 
targeted effects that enabled the reconstruction of the entire pathway, when occur-
ring within a linear sequence and involving a sufficient number of interruptions. 
By building on naturally occurring lesions, the development of reagents capable 
of modifying DNA rapidly expanded available tools for DNA dissection. With the 
advent of molecular biological procedures gene products could be altered at virtu-
ally any locus, allowing both pathway reconstruction and characterization of whole 
clusters of supramolecular assemblies [18].
The success of pathway reconstruction in metabolism led to the implementation 
of mutagenesis to dissect neural function in simple organisms amenable to genetic 
manipulation, like C. elegans and Drosophila on the presupposition that such simple 
functions were composed of similar molecular sequences; later applied for more 
complex neural functions like learning. This presupposition was consistent with the 
nearly universal cellular use of enzymatic catalysis to drive molecular and supramo-
lecular events. It was consistent, moreover, with what was known of causally sequen-
tial events that occurred in neural operation, like the activation of synaptic vesicle 
release following the arrival of an action potential at a synapse. Hence, the use of the 
strategy extended apparently reasonable presuppositions about the construction of 
underlying processes to higher neural function.
The success of the mutagenesis strategy for elucidating biochemical path-
ways, which had motivated its use for exploring neural function, however, 
was due to a fortuitous confluence that juxtaposed the compositional nature of 
metabolism - with its linear and precise factory like assembly - with a causal 
conception involving successive influences effected via steplike sequences. 
Applied to neural function this conception analogized photopotential generation 
to a metabolite and the neural events of transduction to successive changes in 
a single molecular substance. Rather than metering the presence of a physical 
product, assessments were thus made in terms of the physiological feature, which 
was viewed as its conceptual equivalent.
Large-scale mutagenesis of fruit flies generated numerous “risk alleles” affect-
ing various components of the photopotential, including its onset, maintenance, 
termination, and facilitation [19–22]. The strategy usefully characterized highly 
Redirecting Alzheimer Strategy - Tracing Memory Loss to Self Pathology
4
penetrant alleles with Mendelian-like features, such as those affecting the photopig-
ment protein, and physical components directly mediating the photopotential, like  
temperature-sensitive channel variants. However, while the strategy yielded 
numerous novel observations about photoreceptor function—including insight 
into mechanisms of prolonged potential activation, habituation-like responses, and 
degenerative cascades—the resolution of transduction per se was less easily and 
less well resolved. With hindsight and drawing from ongoing parallel studies of 
phototransduction that did not resort to genetic studies, the lack of resolution may 
now be partially traced to the conceptual equating of a physical component with a 
physiological function. Differences in the physical instantiation of a function - as 
opposed to a metabolite - became notably apparent with the discovery of features 
such as gated switching, nonlinear dynamical gain and the use of multicomponent 
protein complexes [23]. For example, generation of the photopotential is critically 
dependent on the asymmetric distribution of Na and K ions across the photo-
receptor cell membrane. Yet, the ionic distribution is not itself generated by the 
transduction event but is an a priori condition that is required to successfully elicit 
the photopotential, one that must be maintained continuously against a concentra-
tion gradient by energy-consuming ionic pumps. A mutation rendering the pumps 
ineffective—for example, through a temperature-sensitive, cell mosaic line—would 
result in the absence of the photopotential and so be interpreted as affecting a step 
in the transduction pathway. Likewise, the photopotential amplitude displays gain 
adjustments that enable the detection of intensity variation under widely variant 
background illumination conditions affecting but not directly constituting the 
phototransduction events. These observations reveal that unlike the succession 
of steps occurring in metabolite processing the generation of the photopotential 
entails a coordinated operation of multiple independent functionalities that are 
each necessary but not sufficient for the potential to occur. Because each of these 
functionalities is potentially influenced by multiple alleles, the number of alleles 
affecting the transduction mechanism is likely to be much larger than that needed 
in a simple sequence of molecular alterations involving a single substance. In other 
words, the number of risk alleles that could affect the function is likely to be consid-
erably more than the number of processional events needed to yield the function and 
indeed is likely to multiply that number. The magnitude of this multiplicative effect 
becomes especially significant when scaled for complex neural events. Accordingly, 
differences between the physical mechanisms of metabolism and those of photo-
potential generation require that the equating of neural function with metabolite 
processing be reconceived, a conceptual adjustment revealed through the findings of 
the mutagenesis approach.
3. Massive allelic effects in cognition
Phototransduction clearly constitutes a moderately complex but nonetheless 
basic function that has evolved to capture light information, in which multiple 
functionalities work together to yield the photopotential. As a neural mechanism, 
however, its level of complexity is arguably much less than many behavioral mecha-
nisms operating at systemic and global scales. Motor execution and action iden-
tification, for example, require the involvement of visual pathways, task positive 
frontoparietal networks, premotor and motor cortices, and cerebellar circuits [24]. 
These are further complicated by the need to evoke egocentric frameworks in goal-
directed actions. Consistent with these broad operational requirements, key risk 
alleles for major cognitive etiopathologies like schizophrenia—with a prevalence of 
0.5–1%—are now known to include more than 120 significant loci, that is, alleles 
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that introduce statistically significant changes in manifest clinical symptoms [25]. 
Moreover, the rate of increase in their discovery has accelerated in recent years, not 
slowed. Classically, traits governed by large numbers of alleles yield only marginal 
and quantitative trait variation, with significant changes observed only in cases of 
rare alleles with high penetrance. Accordingly, many more difficult to detect alleles 
are likely to also contribute to the manifestation of the disease. In like manner, 
genetic studies of AD have also identified numerous risk alleles contributing to its 
etiopathology [26].
Together, the genetic studies show that cognitive diseases, as a group, are poly-
genic, often influencing hundreds of known alleles with perhaps a much greater 
unidentified number also influencing disease severity. Variation in behavioral 
effects due to any single allele, moreover, is small, with observed changes likely to 
be of a quantitative rather than a qualitative nature. Alone, the use of risk alleles as a 
strategical undertaking is therefore unlikely to offer significant insight into a causal 
etiology. The studies, rather, implicate large numbers of affected neurons and 
circuits, that is, effects likely to be mediated at systemic and even organismal levels 
of neural function. The range of investigations that have been undertaken over 
decades of exploration, in fact, from single allele variation to genome-wide inves-
tigations reveal that while genetic influences are clearly at work in cognition—such 
diseases typically display statistically significant familial effects—such influences 
are apparently mediated through a complex overarching matrix of constraints, one 
that bears little resemblance to a stepwise biochemical sequence, for which allele 
study and mutational analyses were first and successfully used.
4. Exploring strategic options in hierarchy
The massive number of affected alleles and the generally enigmatic character of 
cognitive diseases—more than 13 different, major hypotheses have been advanced 
to date to explain AD etiopathology—pose significant quandaries in the selection 
of research strategies, which clearly have as their ultimate objective whole rather 
than partial and ineffective therapeutic intervention. In light of these realities 
that seem linked to the extraordinarily complex scales of cognitive operation, the 
observations from mutagenesis strategies of intermediate-level phenomena like the 
photopotential offer a strong stimulus for moving beyond purely reductive options 
in the strategic analysis of cognitive disease etiology.
The recognition that functions often require supramolecular structures, for 
instance, has motivated the use of proteomics to characterize large-scale protein 
aggregates. This move would dispense with the lower-level allele studies and focus 
on how function emerges from clusters of interacting units. Such an approach also 
holds a promise for its access to the technical virtuosity acquired over decades in the 
use of translational technologies and analytical protein and peptide biochemistries. 
In principal virtually any protein segment can now be modified and analyzed to 
ascertain how such changes causally interact with other protein components to yield 
specific functions.
For example, the flagellar motor that propels bacterial motion is a well-characterized 
example of a large supramolecular aggregate consisting of more than seven distinct 
proteins activated during chemotaxis. Ligand-based stimuli, internal-based phos-
phorylation modifications, and enhanced protein-binding interactions are now all 
known events discerned through proteomic studies. These mechanical features are an 
important aspect of explaining the causal succession for the motor’s function, identified 
in philosophy of science accounts as the “how” question in functional explanation [27]. 
The motor’s performance, however, must also conform to an organizational, that is, 
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design, principle to be functional, which is to say that the explanation for the motor’s 
function must include a dimension beyond that of the succession of internal events 
leading to functional output. This latter explanation, termed the “why” question, is 
significant for revealing that efficient causal interactions require the design principle as 
an a priori condition for their realization, hence, answers to the ‘how’ question repre-
sent only causal outcomes of organizational form.
This invocaton of design principle is significant for identifying the primary 
causal origin of a function. Rather than determined from below, the mechanistic 
steps emerge from a predetermined order that is critical for defining material 
composition and operation. Moreover, the elicited function—the motor’s operation, 
for example—is framed within the context of global organismal need. Accordingly, 
the emergence of the function is fundamentally related to non-reductive, top-down 
effects that reflect two aspects of organismal operation; first, an organizational 
order that governs associations of larger-order complexes (e.g., evident in motifs 
and network analysis) and, second, a global requirement to satisfy organismal 
need, seen, for instance, in goal directed activity.
Conceiving of neural function from this higher-order perspective—i.e, dynami-
cally oriented and not static as in the conception of metabolites—has implications 
for considering the primacy of causes eliciting neural organization—not chiefly 
through the structuring of its anatomical features, where it is built from the bottom 
up, but as a dynamic and functional order that has a purposeful orientation, which 
is determined from the top down.
5. Pursuing top-down strategy in autonomy and goal-directed behavior
Viewed from the dynamic aspect of function, the order of causal priority is 
reversed where the chief influences underlying organization and performance are 
systemic and teleological. Lesions of higher-order neural functions, like memory, 
appear thereby as dysfunctional properties of global representations. Risk alleles, in 
this reading, and similar reductive approaches can be expected to offer little insight 
into cognitive operation at the level of neural constructs likely to be impaired in 
cognitive diseases. Investigations into cognition, instead, seem better directed when 
exploring the operation of extended networks that function as components of 
larger systemic or even global operations. By extension, lesions that may fruitfully 
reveal aspects of large-scale operation are more likely to involve systemic effects 
that are more closely apposed to global processes mediating organismal tasking.
Models that define the source of this tasking, accordingly, are likely to be helpful 
for identifying the sorts of lesions that can be usefully exploited for cognitive study. 
Key features underwriting global cognition notably include those preserving existen-
tial independence and the integration of the organism as a whole, that is, those pro-
viding for autonomous existence [28]. Understood as a capacity, autonomy implicates 
dispositional qualities of self-recognition and self-directedness; that is, it invokes 
self-constructs that elicit higher order operations, which, accordingly, can be dis-
rupted by cognitive disease. As one such higher order operation, for instance, memory 
is directly elicited by such self constructs in order to facilitate autonomy. Lesions of 
higher-order capacities like memory, which are evoked by global constructs, may thus 
be usefully exploited for their properties and manner of elicitation [29, 30].
Emerging from the global operation of the brain, constructs like the self are 
clearly extraordinarily complex and in many respects seem less tangible than mate-
rial constituents of reductive and low-level functions. Nonetheless, their organis-
mal reality is clearly evident in manifestations of behavioral activity. For example, 
the association between a representation of the whole individual by his body and its 
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physical realization in the neural activity of the brain, that is, as a global brain state, 
is consistently observed in varied perceptual realizations of the self. And in another 
example the failure of infants in the A not B task to move toward a goal where last 
seen is interpreted as a failure in motor planning due to maturational insufficiency 
in mechanisms needed to situate the motor plan that are associated with represent-
ing the self as the whole body [31]. These examples suggest that top down aproaches 
can offer strategic alternatives that more readily yield insight into global brain 
operations that are manifested at organismal scales.
Indeed, the modern concept of the neural representation of the self, for example, 
evoked in circumstances where the body is dynamically engaged in intentional 
actions, is an increasingly well-understood global operation that has emerged from 
several experimental legacies traced to the notion of the motor image [24]. The 
image is now known to involve a covert action undertaken only mentally and as a 
simulation of a non-executed action, with current evidence suggesting that there is 
a close correspondence between goal-directed information and self-representation 
[32]. Mechanisms that are likely to shape self-content can therefore be expected to 
include, for example, cells, circuits, or processes that bear desires and intentions of 
the author, which are likely to be contained in egocentric networks [33], and which 
encode agent specific content about an experience. These have been sited to specific 
domains of the hippocampus, such as the lateral entorhinal cortex where they appear 
to be influenced by memory recall [34] such as the lateral entorhinal cortex, and to 
the angular gyrus of the parietal cortex, a region that has been previously identified 
with self- and bodily representation. Indeed, goal-directed information contained in 
these networks can be expected to uniquely modify the self-representation by relat-
ing the individual to an intended terminus via information that is goal specific.
6. Reconsidering lesions: AD and KS in top-down strategic analysis
The promise of top-down analysis predicts that global organization is selec-
tively impaired at intermediate and even higher levels of brain function, such as 
those now being investigated through the motor plan. Indeed, disturbances in the 
sense of self that mark schizophrenia, for example, in prodromal and acute stages, 
have led to the recognition of the loss of self as a core symptom [35] where both 
body ownershipa nd sense of agency are impacted [36]. Current evidence on how 
representational content of the self may be affected and how this may be linked to 
the body suggest, in fact, that it is mediated through the motor plan, which thereby 
offers a strategic investigative tool. Insight into the neural features that these results 
may implicate, for example, can be inferred from misattribution errors that are 
experimentally evoked in normal individuals and that appear to be pathologically 
exacerbated in schizophrenic individuals [37].
By extension, memory losses in AD and KS are in their broad features consis-
tent with functional losses that have organismal bearing and that can be revealed 
through such top-down analysis. Accordingly, this volume represents an effort 
to forward an argument for global strategies that can be pursued in cognitive 
etiopathologies. It is a proposal that emerges from the intractability of reductive 
study faced with the incredible complexity of operation that is intrinsic to cogni-
tion. While lacking in the tangible manifestations that have come to mark genetic 
and molecular study, the reality of global operation is nonetheless manifestly 
evident. Moreover, it is a reality for which new investigative tools are emerging 
from research studies, such as the motor plan. Revelation of distinct functional 
differences in memory loss in diseases like AD and KS, therefore, can be expected to 
further options for global, top-down study.
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